{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T23:41:34Z","timestamp":1795218094591,"version":"4.10.3"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Breast cancer (BC) remains the most prevalent malignancy among women globally, encompassing a variety of tumor subtypes with differing biological behaviors, prognoses, and responses to treatment. Among these, invasive ductal carcinoma (IDC) is the most common, followed by other subtypes such as lobular carcinoma and triple-negative breast cancer. Metaplastic breast carcinoma (MpBC) is a rare and highly aggressive form of BC, representing less than 2% of cases. Characterized by its heterogeneous nature and poorer prognosis compared to other BC subtypes, MpBC often presents significant diagnostic and therapeutic challenges.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case description:<\/jats:title>\n            <jats:p>We present the case of a 70-year-old woman who presented to our breast care clinic with right mastodynia following a recent trauma. She reported a palpable retro-areolar mass in the right breast that had increased in size over several years and was associated with calcifications. Imaging studies, including mammography and ultrasound, revealed a 3-cm irregular, heavily calcified mass with indistinct borders. Histological analysis of a biopsy confirmed metaplastic carcinoma with chondrosarcoma and osteosarcoma elements, high histological grade, and lymphovascular involvement. The patient underwent successful tumor excision with sentinel lymph node removal. Adjuvant chemotherapy and radiotherapy were planned based on a multidisciplinary team\u2019s recommendations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>MpBC typically presents as a palpable, irregular mass that may exhibit rapid growth or changes, often complicating its differentiation from other breast malignancies. Standard imaging techniques like mammography and ultrasound may fail to clearly distinguish MpBC from other tumors, leading to potential misdiagnosis. The heterogeneous nature of MpBC, with both epithelial and mesenchymal components, poses additional challenges in diagnosis and treatment. Although MpBC is generally more aggressive and less responsive to conventional therapies compared to IDC, recent analyses suggest that, when adjusted for confounding factors, survival outcomes for MpBC may align more closely with those of aggressive IDC subtypes. Current treatment strategies include surgery, chemotherapy, and radiotherapy, with emerging targeted therapies offering potential for improved outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>MpBC remains a rare and challenging BC subtype with a typically poor prognosis. Our case highlights the diagnostic difficulties and the aggressive nature of MpBC. Despite its severe clinical features and histological grades, survival outcomes for MpBC may be comparable to those of aggressive IDC subtypes when appropriate treatment adjustments are made. Continued research into targeted therapies and novel treatment approaches is essential to enhance management strategies and improve outcomes for patients with MpBC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000002816","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T16:00:09Z","timestamp":1734624009000},"page":"985-990","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Metaplastic breast carcinoma: a rare and aggressive entity"],"prefix":"10.1097","volume":"87","author":[{"given":"Manar","family":"Zaiter","sequence":"first","affiliation":[{"name":"Department of Radiology, MEIH, Bsalim, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Naccour","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, MSF, Bourj Hammoud, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faten","family":"Khalil","sequence":"additional","affiliation":[{"name":"Department of Radiology, LU, Hadath, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"El-Helou","sequence":"additional","affiliation":[{"name":"Department of Surgical oncology, STMC, Hadath, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"R1-20250623","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast"},{"key":"R2-20250623","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/s41379-021-00742-9","article-title":"Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations","volume":"34","author":"Bergeron","year":"2021","journal-title":"Mod Pathol"},{"key":"R3-20250623","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3390\/cancers15051556","article-title":"Clinical characteristics and prognosis of metaplastic breast cancer compared with invasive ductal carcinoma: a propensity-matched analysis","volume":"15","author":"Lee","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R4-20250623","first-page":"e28551","article-title":"Metaplastic breast cancer: characteristics and survival outcomes","volume":"14","author":"Thapa","year":"2022","journal-title":"Cureus"},{"key":"R5-20250623","first-page":"35","article-title":"Metaplastic carcinoma of the breast: case series of a single institute and review of the literature","volume":"11","author":"Papatheodoridi","year":"2023","journal-title":"Med Sci (Basel)"},{"key":"R6-20250623","doi-asserted-by":"crossref","first-page":"100329","DOI":"10.1016\/j.jpi.2023.100329","article-title":"Predicting breast cancer-specific survival in metaplastic breast cancer patients using machine learning algorithms","volume":"14","author":"Feng","year":"2023","journal-title":"J Pathol Inform"},{"key":"R7-20250623","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/JS9.0000000000000373","article-title":"The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines","volume":"109","author":"Sohrabi","year":"2023","journal-title":"Int J Surg Lond Engl"},{"key":"R8-20250623","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000441288","article-title":"Metaplastic breast carcinoma with unusual presentation: review of three cases","volume":"10","author":"Fern\u00e1ndez P\u00e9rez","year":"2015","journal-title":"Breast Care (Basel)"},{"key":"R9-20250623","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1258\/ar.2011.110341","article-title":"Metaplastic carcinoma of the breast: multimodality imaging and histopathologic assessment","volume":"53","author":"Choi","year":"2012","journal-title":"Acta Radiol"},{"key":"R10-20250623","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41598-022-04946-0","article-title":"Chemotherapy significantly improves long-term survival of small lesion node negative metaplastic breast carcinoma in T1c population rather than T1a and T1b","volume":"12","author":"Chen","year":"2022","journal-title":"Sci Rep"},{"key":"R11-20250623","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/RUQ.0000000000000340","article-title":"Multimodality imaging findings of metaplastic breast carcinomas: a report of five cases","volume":"34","author":"Kim","year":"2018","journal-title":"Ultrasound Q"},{"key":"R12-20250623","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5858\/arpa.2020-0830-OA","article-title":"Clinicopathologic characteristics and outcome descriptors of metaplastic breast carcinoma","volume":"146","author":"Abada","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"R13-20250623","doi-asserted-by":"crossref","first-page":"635237","DOI":"10.3389\/fonc.2021.635237","article-title":"A case series of metastatic metaplastic breast carcinoma treated with anti-PD-1 therapy","volume":"11","author":"Kim","year":"2021","journal-title":"Front Oncol"},{"key":"R14-20250623","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.3390\/ijms22147398","article-title":"Epithelial mesenchymal transition and immune response in metaplastic breast carcinoma","volume":"22","author":"Gonz\u00e1lez-Mart\u00ednez","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T08:01:17Z","timestamp":1750665677000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000002816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000002816","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"2024-09-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}